Mr. Chair, I understand that CIHR, which is our premier research institute that does funding of about $752 million per year for all kinds of research across the country, has announced that it would have a registry of all the clinical trials in the country that it funds or for anybody else that might want to register with it.
I said some time ago shortly after I became the Minister of Health that I believe in full disclosure by all drug companies with respect to the clinical trials they engage in. I want to know the good, the bad and the ugly of the clinical trials before and as those drugs are approved for use in Canada, because it is important that with the exception of commercial interests and some other confidentiality interests we provide full disclosure to Canadians. It is in the interests of Canadians that they know the good, the bad and the ugly of all the clinical trials in Canada. I am in favour of toughening up on this issue.